Study of Lanreotide to Treat Polycystic Kidney Disease (DIPAK1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01616927
Recruitment Status : Active, not recruiting
First Posted : June 12, 2012
Last Update Posted : May 23, 2017
Leiden University Medical Center
Erasmus Medical Center
Radboud University
Information provided by (Responsible Party):
dr. R.T. Gansevoort, University Medical Center Groningen